Psychemedics Revenue, Profits - PMD Quarterly Income Statement

Add to My Stocks
$20 $0.1 (0.5%) PMD stock closing price Jul 20, 2018 (Closing)

Looking at financial statements, along with the Psychemedics stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the PMD stock is bound to reflect the impact of the QOQ growth of 12.09%. One also needs to look at Psychemedics assets, operating expenses and Psychemedics free cash flow. The Psychemedics profit and loss statement shows revenue of $10.94M for 2018 Q1. Revenue has grown by 12.09% QoQ for PMD stock.

View and download details of revenue and profits for Psychemedics for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Psychemedics Revenues or Net Sales
10.94M9.76M10.05M9.68M10.21M10.76M11.85M9.7M6.67M6.13M
Cost Of Goods Sold (COGS)5.58M4.99M4.92M5.07M4.89M4.38M4.74M4.49M3.92M3.49M
Psychemedics Gross Profit
5.35M4.79M5.12M4.6M5.31M6.42M7.1M5.2M2.73M2.67M
Research & Development Expense----------
Selling General & Admin Expense3.09M2.49M2.53M2.57M2.71M2.42M2.65M2.48M2.37M2.2M
Income Before Depreciation Depletion Amortization1.9M1.95M2.23M1.71M2.26M3.64M4.1M2.37M--
Depreciation Depletion Amortization----------
Non Operating Income------0.13M----0.03M
Interest Expense--0.03M----0.09M----
Psychemedics Pretax Income
1.93M2M2.24M1.69M2.24M3.6M4.07M2.33M-0.03M-
Provision for Income Taxes--0.36M---1.24M1.36M--0.01M-0.09M
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations1.25M2.35M1.36M-1.5M2.36M2.71M1.63M-0.02M-
Extraordinary Items & Discontinued Operations----------
Psychemedics Profit/ Loss (Net Income)
1.25M2.35M1.36M-1.5M2.36M2.71M1.63M-0.02M-
Average Shares used to compute Diluted EPS5.44M5.6M5.46M5.34M5.56M5.49M5.51M5.45M5.42M5.42M
Average Shares used to compute Basic EPS5.44M5.6M5.46M5.34M5.56M5.49M5.46M5.44M5.42M5.42M
Income Before Nonrecurring Items1.25M1.25M1.36M-1.5M2.36M2.71M1.63M-0.02M-
Income from Nonrecurring Items-1.1M--------
Psychemedics Earnings Per Share Basic Net
0.230.420.250.170.270.430.500.300.000.03
Psychemedics Earnings Per Share Diluted Net
0.230.420.250.160.270.430.490.300.000.03
EPS Diluted Before Nonrecurring Items0.230.220.250.160.270.430.490.300.000.03
Preferred Dividends Acc Pd----------
Dividends Common0.820.82--------
Dividend Per Share Common0.150.150.150.150.150.150.150.150.150.15
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on Psychemedics stock analysis. It helps to look at the following income statement items:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $10.94M for this quarter of 2018 Q1. Our Psychemedics revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $1.25M for Psychemedics for 2018 Q1. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the PMD income statement, one can check the Psychemedics historical stock prices to check how the price has moved with time.

Psychemedics Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
18.87
PS Ratio (price sales ratio)
2.69
Operating Margin
17.4
Net Profit Margin
11.4
Dividend Yield
3%